Overview

Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain

Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The objectives of this trial are to investigate the efficacy and safety of six weeks of treatment with OLT1177 Gel in subjects with moderate to severe pain associated with osteoarthritis of the knee following cessation of pain therapy.
Phase:
Phase 2
Details
Lead Sponsor:
Olatec Industries LLC
Olatec Therapeutics LLC
Treatments:
Dapansutrile